Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 3,181-3,192 of 10,612

Drug study icon

CompletedNCT01959035

Aripiprazole Once-monthly in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Schizophrenia

Drug study icon

CompletedNCT01795547

Aripiprazole Once-monthly Versus Paliperidone Palmitate in adults with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Schizophrenia

Drug study icon

CompletedNCT00102518

Aripiprazole Safety and Tolerability Study

This study is completed in the United States. It focuses on Schizophrenia.

In United States

Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia, Bipolarity

Drug study icon

CompletedNCT00101569

Aripiprazole Oral Acceptability study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT00276874

Aripiprazole to Reduce Cocaine Relapse

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Craig Rush
Condition: Addiction

Drug study icon

CompletedNCT00198198

Aripiprazole Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Indiana University
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00237874

Aripiprazole Treatment of Prodromal Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 13 Years to 40 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

TerminatedNCT00169949

Aripiprazole Treatment of the Prodrome

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 13 Years to 22 Years

Countries: United States
Sponsor: Northwell Health
Condition: Schizophrenia

Drug study icon

CompletedNCT00325689

Aripiprazole Used as Dual Therapy in the Treatement of people with Chronic Stable Schizophrenia or Schizoaffective Disorder.

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

TerminatedNCT02717130

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Florida Atlantic University
Condition: Schizophrenia

Drug study icon

CompletedNCT01010789

Armodafinil in Binge Eating disorders (BED)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Lindner Center of HOPE
Condition: Eating disorders

Drug study icon

CompletedNCT00481195

Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Hungary, ...
Sponsor: Cephalon
Condition: Bipolarity, Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.